• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏磁共振成像:1.5T与3T对比

Liver MR imaging: 1.5T versus 3T.

作者信息

Ramalho Miguel, Altun Ersan, Herédia Vasco, Zapparoli Mauricio, Semelka Richard

机构信息

Department of Radiology, University of North Carolina at Chapel Hill, CB#7510, 101 Manning Drive, Chapel Hill, NC 27599-7510, USA.

出版信息

Magn Reson Imaging Clin N Am. 2007 Aug;15(3):321-47, vi. doi: 10.1016/j.mric.2007.06.003.

DOI:10.1016/j.mric.2007.06.003
PMID:17893053
Abstract

This article focuses on technical challenges in transferring 1.5T liver protocols to 3T systems and the overall comparison of MR sequences, highlighting the advantages and disadvantages of imaging at the higher field strength. An important benefit is the capacity of acquiring high-quality, thin-section postgadolinium T1-weighted three-dimensional gradientecho sequences, most clinically relevant for the detection and characterization of small hypervascular malignant diseases. Further research and development is necessary to overcome disadvantages, such as with in- and out-of phase T1-weighted gradient-echo sequences, and to minimize artifacts that appear at 3T.

摘要

本文重点关注将1.5T肝脏检查方案转换至3T系统时的技术挑战以及磁共振序列的总体比较,突出了在更高场强下成像的优缺点。一个重要的优势是能够获取高质量的、薄层的钆增强后T1加权三维梯度回波序列,这对于检测和鉴别小的富血供恶性病变最为相关。有必要进行进一步的研发以克服缺点,比如同相位和反相位T1加权梯度回波序列的缺点,并尽量减少在3T时出现的伪影。

相似文献

1
Liver MR imaging: 1.5T versus 3T.肝脏磁共振成像:1.5T与3T对比
Magn Reson Imaging Clin N Am. 2007 Aug;15(3):321-47, vi. doi: 10.1016/j.mric.2007.06.003.
2
MR colonography: 1.5T versus 3T.磁共振结肠成像:1.5T与3T对比
Magn Reson Imaging Clin N Am. 2007 Aug;15(3):395-402, vii. doi: 10.1016/j.mric.2007.06.006.
3
3.0-T MRI evaluation of patients with chronic liver diseases: initial observations.3.0-T磁共振成像对慢性肝病患者的评估:初步观察
Magn Reson Imaging. 2008 Jun;26(5):650-60. doi: 10.1016/j.mri.2008.01.037. Epub 2008 Apr 28.
4
MR imaging of the liver. Technique.肝脏的磁共振成像。技术。
Magn Reson Imaging Clin N Am. 1997 May;5(2):205-21.
5
Abdominal MR imaging at 3T.3T腹部磁共振成像。
Magn Reson Imaging Clin N Am. 2006 Feb;14(1):17-26. doi: 10.1016/j.mric.2005.12.001.
6
Hepatic MR imaging techniques, optimization, and artifacts.肝脏磁共振成像技术、优化及伪影。
Magn Reson Imaging Clin N Am. 2014 Aug;22(3):263-82. doi: 10.1016/j.mric.2014.04.004.
7
MR imaging of the adrenal glands: 1.5T versus 3T.
Magn Reson Imaging Clin N Am. 2007 Aug;15(3):365-72, vii. doi: 10.1016/j.mric.2007.06.008.
8
A review of MR physics: 3T versus 1.5T.磁共振物理学综述:3T与1.5T对比
Magn Reson Imaging Clin N Am. 2007 Aug;15(3):277-90, v. doi: 10.1016/j.mric.2007.06.002.
9
Kidneys and MR urography.肾脏与磁共振尿路造影。
Magn Reson Imaging Clin N Am. 2007 Aug;15(3):373-82, vii. doi: 10.1016/j.mric.2007.06.007.
10
Small bowel MR imaging: 1.5T versus 3T.
Magn Reson Imaging Clin N Am. 2007 Aug;15(3):383-93, vii. doi: 10.1016/j.mric.2007.07.002.

引用本文的文献

1
ESGAR consensus statement on MR imaging in primary sclerosing cholangitis.欧洲胃肠道和腹部放射学会关于原发性硬化性胆管炎磁共振成像的共识声明。
Eur Radiol. 2025 Apr 26. doi: 10.1007/s00330-025-11583-4.
2
Efficacy of compressed sensing and deep learning reconstruction for adult female pelvic MRI at 1.5 T.1.5T 成人女性盆腔 MRI 压缩感知与深度学习重建的效能。
Eur Radiol Exp. 2024 Sep 10;8(1):103. doi: 10.1186/s41747-024-00506-5.
3
Diagnostic accuracy of diffusion weighted MRI in differentiating malignant from benign liver lesions taking histopathology as gold standard.
以组织病理学为金标准,扩散加权磁共振成像在鉴别肝脏良恶性病变中的诊断准确性。
Pak J Med Sci. 2024 Mar-Apr;40(4):669-673. doi: 10.12669/pjms.40.4.7738.
4
Current status of imaging in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的影像学现状
World J Hepatol. 2018 Aug 27;10(8):530-542. doi: 10.4254/wjh.v10.i8.530.
5
Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows.对通过功能和形态学MRI评估的127例经证实的肝细胞癌(HCC)的LI-RADS主要和辅助影像学特征进行批判性分析:亮点与阴影。
Oncotarget. 2017 Apr 19;8(31):51224-51237. doi: 10.18632/oncotarget.17227. eCollection 2017 Aug 1.
6
Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials.肝脏的磁共振成像(包括胆道造影剂)第1部分:技术考量与造影剂
Semin Roentgenol. 2016 Oct;51(4):308-316. doi: 10.1053/j.ro.2016.05.015. Epub 2016 May 30.
7
Non-contrast-enhanced hepatic MR arteriography with balanced steady-state free-precession and time spatial labeling inversion pulse: optimization of the inversion time at 3 Tesla.采用平衡稳态自由进动和时间空间标记反转脉冲的非增强肝脏磁共振动脉造影:3特斯拉下反转时间的优化
Acta Radiol Open. 2015 Nov 27;4(12):2058460115616427. doi: 10.1177/2058460115616427. eCollection 2015 Dec.
8
Focal liver lesions: Practical magnetic resonance imaging approach.肝脏局灶性病变:实用磁共振成像方法
World J Hepatol. 2015 Aug 8;7(16):1987-2008. doi: 10.4254/wjh.v7.i16.1987.
9
3.0 Tesla magnetic resonance imaging: A new standard in liver imaging?3.0特斯拉磁共振成像:肝脏成像的新标准?
World J Hepatol. 2015 Jul 28;7(15):1894-8. doi: 10.4254/wjh.v7.i15.1894.
10
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.欧洲胃肠道和腹部放射学会关于肝脏磁共振成像及肝脏特异性对比剂临床应用的共识声明。
Eur Radiol. 2016 Apr;26(4):921-31. doi: 10.1007/s00330-015-3900-3. Epub 2015 Jul 21.